Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Verrica Pharmaceuticals Inc. (VRCA) had Debt to Capital Ratio of 0.03 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$5.02M |
|
$-9.68M |
|
$0.89M |
|
$4.13M |
|
$14.74M |
|
$-9.71M |
|
$0.03M |
|
$-9.68M |
|
$-9.68M |
|
$-9.68M |
|
$-9.68M |
|
$-9.68M |
|
$-9.68M |
|
$-9.71M |
|
$-9.52M |
|
21.30M |
|
21.30M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$34.13M |
|
$0.19M |
|
$4.66M |
|
$38.79M |
|
$16.22M |
|
$0.55M |
|
$6.51M |
|
$22.73M |
|
$16.05M |
|
$16.05M |
|
$16.05M |
|
17.18M |
|
| Cash Flow Statement Financials | |
$-9.16M |
|
-- |
|
$-0.12M |
|
$30.15M |
|
$20.86M |
|
$-9.28M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.10 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.03 |
0.06 |
|
82.30% |
|
-193.41% |
|
-193.41% |
|
-- |
|
-192.75% |
|
-192.75% |
|
$-9.16M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.45 |
|
0.64 |
|
139.99 |
|
-60.31% |
|
-60.31% |
|
-24.96% |
|
-58.32% |
|
$0.93 |
|
$-0.43 |
|
$-0.43 |
|